Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Altitude Crest Partners Inc. (CIK 1986035) reported $233.6M across 30 reported positions in its SEC 13F filing for 2024-03-31. Largest positions: LEGN ($36.6M, 15.67%), DHR ($27.1M, 11.62%), BBIO ($18.9M, 8.10%), STVN ($17.7M, 7.56%), APLS ($16.9M, 7.23%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | LEGN | LEGEND BIOTECH CORP | $36.6M | 15.67% | 652,732 | Added |
| 2 | DHR | DANAHER CORPORATION | $27.1M | 11.62% | 108,700 | Trimmed |
| 3 | BBIO | BRIDGEBIO PHARMA INC | $18.9M | 8.10% | 612,060 | Trimmed |
| 4 | STVN | STEVANATO GROUP S P A | $17.7M | 7.56% | 550,000 | New |
| 5 | APLS | APELLIS PHARMACEUTICALS INC | $16.9M | 7.23% | 287,277 | Added |
| 6 | TMO | THERMO FISHER SCIENTIFIC INC | $10.7M | 4.58% | 18,400 | New |
| 7 | AVBP | ARRIVENT BIOPHARMA INC | $9.9M | 4.25% | 555,555 | New |
| 8 | GPCR | STRUCTURE THERAPEUTICS INC | $8.8M | 3.76% | 205,166 | New |
| 9 | KNSA | KINIKSA PHARMACEUTICALS LTD | $7.9M | 3.38% | 400,441 | Trimmed |
| 10 | JANX | JANUX THERAPEUTICS INC | $7.3M | 3.12% | 193,300 | New |
| 11 | LLY | ELI LILLY & CO | $7.2M | 3.06% | 9,200 | New |
| 12 | IMNM | IMMUNOME INC | $6.5M | 2.77% | 262,284 | New |
| 13 | BHVN | BIOHAVEN LTD | $6.5M | 2.77% | 118,380 | New |
| 14 | SWTX | SPRINGWORKS THERAPEUTICS INC | $6.3M | 2.71% | 128,842 | New |
| 15 | GERN | GERON CORP | $5.1M | 2.16% | 1.5M | New |
| 16 | ICLR | ICON PLC | $5.0M | 2.13% | 14,800 | New |
| 17 | MRUS | MERUS N V | $4.9M | 2.12% | 109,837 | New |
| 18 | ROIV | ROIVANT SCIENCES LTD | $4.8M | 2.05% | 454,766 | Trimmed |
| 19 | DNLI | DENALI THERAPEUTICS INC | $4.3M | 1.84% | 209,613 | New |
| 20 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $4.1M | 1.74% | 103,703 | New |
| 21 | AGIO | AGIOS PHARMACEUTICALS INC | $3.3M | 1.42% | 113,100 | New |
| 22 | DAWN | DAY ONE BIOPHARMACEUTICALS I | $3.2M | 1.38% | 195,497 | New |
| 23 | ALGS | ALIGOS THERAPEUTICS INC | $2.8M | 1.19% | 2.8M | Hold |
| 24 | ENGN | ENGENE HOLDINGS INC | $2.0M | 0.87% | 120,289 | New |
| 25 | APLT | APPLIED THERAPEUTICS INC | $1.8M | 0.76% | 259,700 | New |
Source: SEC Form 13F filings · as of 2024-03-31